Swarms of nanoparticles which are 15,000 times smaller than a pinhead may be able to deliver vital drugs to the brain, offering new hope to stroke patients.
More than 130 people joined The Oral Health Foundation yesterday, at the Houses of Parliament, as the charity announced this year's Mouth Cancer Action Month.
Young people with cancer are potentially being robbed of the ability to have children as important information around fertility is not being communicated at the earliest opportunity says the cancer charity, Teenage Cancer Trust.
In this exclusive interview with Prof Olufunmilayo Lesi, Regional Medical Officer for Viral Hepatitis from the World Health Organization (WHO) Office for the Africa Region, discusses tackling viral hepatitis in Africa.
After a career spanning more than 20 years, a Swansea University Professor’s passion for research is as ‘strong as ever’, as he marks a very notable achievement – the release of his 100th cancer research paper.
Using cross-disciplinary technology, Dr Kunio Matsumoto, PhD, Professor at Kanazawa University in Japan is extending research on growth factor toward synthetic biologics for regeneration-based medicine and cancer theranostics.
Regina Fluhrer from the University of Augsburg and Bernd Schröder from the TU in Dresden discuss the potential of intramembrane proteases as targets for cancer therapies.
Redefining efficiency based on what matters to cancer patients is placed under the spotlight here by All.Can, including identifying opportunities for change.
John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
Here, Haruki Komatsu discusses how Paediatric Hepatitis B virus (HBV) infection is one of the main things which can lead to liver cirrhosis and hepatocellular carcinoma.
Scientists have determined a new way to protect the hair follicle from chemotherapy in an effort to prevent hair loss as a result of cancer treatments.
